Argentarii’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.07M Sell
1,589
-12
-0.7% -$7.13K 0.33% 66
2026
Q2
$969K Sell
1,601
-4
-0.2% -$1.92K 0.29% 74
2026
Q1
$789K Buy
1,605
+328
+26% +$178K 0.28% 85
2025
Q4
$740K Buy
1,277
+347
+37% +$196K 0.24% 87
2025
Q3
$451K Sell
930
-94
-9% -$43.8K 0.18% 94
2025
Q2
$415K Sell
1,024
-784
-43% -$328K 0.19% 98
2025
Q1
$900K Sell
1,808
-67
-4% -$36.3K 0.45% 59
2024
Q4
$975K Buy
+1,875
New +$1.03M 0.49% 52

Other funds holding TMO

Argentarii's TMO Position: Q3 2026 in Review

Argentarii reduced its Thermo Fisher Scientific (TMO) stake by 0.75% in Q3 2026, selling an estimated $7.13K and leaving 1,589 shares worth $1.07M. The position accounts for 0.33% of the portfolio, ranked #66.

Argentarii first reported a position in TMO in Q4 2024 and has held it in 8 quarters since. 1,167 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Argentarii held 1,589 shares of Thermo Fisher Scientific worth $1.07M as of Q3 2026.
  • Argentarii sold 12 Thermo Fisher Scientific shares in Q3 2026, an estimated $7.13K.
  • Thermo Fisher Scientific made up 0.33% of Argentarii's portfolio in Q3 2026, its #66 holding.
  • Argentarii first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 8 quarters since.
  • 1,167 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Argentarii's 13F filing for Q3 2026, filed 28 Oct 2026.